Renal Outcomes and Factors Predicting the Outcomes after Conversion to Sirolimus from Calcineurin Inhibitors in Chronic Renal Allograft Dysfunction.

被引：0
|
作者：
Swaminathan, Ramyasuda [1 ]
Irish, Ashley [1 ]
机构：
[1] Royal Perth Hosp, Perth, WA, Australia
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：585 / 585
页数：1
相关论文
共 50 条
  • [31] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function.
    Moneim, HA
    Flechner, SM
    George, P
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, D
    Novick, AC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 376 - 377
  • [32] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [33] Chronic allograft damage index (CADI) scoring at conversion from calcineurin inhibitors (CI) to Sirolimus predicts renal outcome in kidney transplant recipients.
    Sankaranarayanan, N
    Balarezo, F
    Alleman, K
    Brown, M
    Charpentier, K
    Lally, A
    Hull, D
    Ranga, KV
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 296 - 296
  • [34] Conversion from cyclosporine/sirolimus (CsA/SRL) to mycophenolate mofetil/sirolimus (MMF/SRL) in patients with chronic allograft dysfunction.
    Fonseca, CC
    Felipe, CR
    Motegi, SA
    Hosaka, BH
    Tanaka, MK
    Kamura, LA
    Park, SI
    Machado, PG
    Garcia, R
    Tedesco-Silva, H
    Medina-Pestana, JO
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 220 - 220
  • [35] Renal calcium handling after rapamycin conversion in chronic allograft dysfunction
    Wu, MS
    Hung, CC
    Chang, CT
    TRANSPLANT INTERNATIONAL, 2006, 19 (02) : 140 - 145
  • [36] Long-Term Effects of Conversion from Calcineurin Inhibitors to Sirolimus for the Recipients with Low Immunological Risk in Renal Allograft.
    Wu, Q.
    Chen, J.
    Cheng, D.
    Ni, X.
    Li, X.
    Xie, K.
    Jiqiu, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1093 - 1094
  • [37] Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation
    Campbell, Mical S.
    Rai, Jitha
    Kozin, Elliott
    Bloom, Roy D.
    Markmann, James F.
    Olthoff, Kim M.
    Shaked, Abraham
    Reddy, K. Rajender
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 377 - 384
  • [38] Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy
    Falger, Jutta C.
    Mueller, Thomas
    Arbeiter, Klaus
    Boehm, Michael
    Regele, Heinz
    Balzar, Egon
    Aufricht, Christoph
    PEDIATRIC TRANSPLANTATION, 2006, 10 (05) : 565 - 569
  • [39] Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy
    Falger, Jutta C.
    Mueller, Thomas
    Arbeiter, Klaus
    Boehm, Michael
    Regele, Heinz
    Balzar, Egon
    Aufricht, Christoph
    PEDIATRIC TRANSPLANTATION, 2006, 10 (04) : 474 - 478
  • [40] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
12345